# Lu Daopei Medical Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lu-daopei-medical-group

- Industry: Healthcare
- Headquarters: Beijing, China
- Website: www.daopei.net
- Total disclosed funding: $86M
- Latest round: Series B (Sep 7, 2020)
- Investors on record: 10

## About

Founded in 2001 and based in Beijing, China, Lu Daopei Medical Group operates a chain of medical institutions that focuses on research and development (R&D) of blood diseases and hematopoietic stem cell transplantation. Lu Daopei Medical Group also provides medical services and treatments on diseases such as lymphoma, myeloma, and other hematology diseases. The founder of the company is Dr. Daopei Lu, who is also the founder of the Institute of Hematology at Peking University.

## Funding rounds

- Series B, Sep 7, 2020, $15M — SB China Venture Capital, CMS Capital, Partner Capital Group, In Capital, Pudao Medical
- Series B, Jul 22, 2020, $72M — Temasek Holdings, Investcorp, Park Je Investment
- Series A, Apr 19, 2016 — Hillhouse Investment, CBC Group

## Investors

- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series A
- CBC Group (https://capitalatlas.ai/funds/cbc-group) — Series A
- Temasek Holdings — Series B
- Investcorp — Series B
- Park Je Investment — Series B
- SB China Venture Capital (https://capitalatlas.ai/funds/sb-china-venture-capital) — Series B
- CMS Capital — Series B
- Partner Capital Group — Series B
- In Capital — Series B
- Pudao Medical — Series B